RUSSO, Massimo
 Distribuzione geografica
Continente #
EU - Europa 6.279
NA - Nord America 6.142
AS - Asia 4.130
SA - Sud America 1.103
Continente sconosciuto - Info sul continente non disponibili 408
AF - Africa 107
OC - Oceania 11
Totale 18.180
Nazione #
US - Stati Uniti d'America 5.934
RU - Federazione Russa 2.976
SG - Singapore 2.200
BR - Brasile 928
CN - Cina 895
IT - Italia 763
IE - Irlanda 751
SE - Svezia 479
HK - Hong Kong 374
DE - Germania 309
PL - Polonia 223
FR - Francia 220
FI - Finlandia 196
VN - Vietnam 184
IN - India 132
GB - Regno Unito 111
CA - Canada 85
UA - Ucraina 80
BD - Bangladesh 65
AR - Argentina 56
MX - Messico 49
TR - Turchia 40
EC - Ecuador 36
ID - Indonesia 32
JP - Giappone 31
ZA - Sudafrica 31
NL - Olanda 30
AT - Austria 25
BE - Belgio 25
IQ - Iraq 23
MA - Marocco 23
CI - Costa d'Avorio 22
CO - Colombia 22
ES - Italia 20
UZ - Uzbekistan 20
LT - Lituania 19
PK - Pakistan 19
VE - Venezuela 18
CL - Cile 16
JM - Giamaica 13
AZ - Azerbaigian 12
CR - Costa Rica 11
KE - Kenya 11
PH - Filippine 10
PY - Paraguay 10
SA - Arabia Saudita 10
CZ - Repubblica Ceca 9
DO - Repubblica Dominicana 9
HN - Honduras 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
EU - Europa 8
MY - Malesia 8
TN - Tunisia 8
CH - Svizzera 7
IL - Israele 7
NP - Nepal 7
GT - Guatemala 6
NI - Nicaragua 6
PT - Portogallo 6
JO - Giordania 5
OM - Oman 5
TH - Thailandia 5
BH - Bahrain 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
LB - Libano 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AL - Albania 3
BO - Bolivia 3
EE - Estonia 3
EG - Egitto 3
GR - Grecia 3
IR - Iran 3
KW - Kuwait 3
PA - Panama 3
PR - Porto Rico 3
RS - Serbia 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BS - Bahamas 2
DM - Dominica 2
DZ - Algeria 2
GA - Gabon 2
KR - Corea 2
LK - Sri Lanka 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
Totale 17.764
Città #
Ashburn 1.052
Moscow 923
Singapore 802
Dublin 747
Chandler 540
Dallas 520
San Jose 429
Hong Kong 374
Beijing 325
Nyköping 321
Council Bluffs 229
Warsaw 221
Messina 206
Jacksonville 188
Munich 157
The Dalles 143
Los Angeles 128
Princeton 128
Ann Arbor 121
Medford 111
Lauterbourg 110
Helsinki 81
Des Moines 79
São Paulo 75
Cambridge 72
Ho Chi Minh City 70
New York 68
Dearborn 67
Buffalo 59
Santa Clara 55
Tianjin 50
Boardman 48
Bremen 41
Wilmington 38
Redondo Beach 37
Orem 36
Turku 35
Jinan 32
Phoenix 31
Pune 31
Rio de Janeiro 30
Brooklyn 29
Frankfurt am Main 28
Houston 28
Chennai 27
Rome 27
Chicago 25
Tokyo 25
Abidjan 22
Atlanta 22
Curitiba 22
Hanoi 22
Hyderabad 22
Seattle 22
Shenyang 22
Brussels 21
Guangzhou 21
Catania 20
Milan 20
Montreal 20
Mexico City 19
Tashkent 19
Brasília 18
Denver 18
Johannesburg 18
San Francisco 18
Nanjing 17
Nuremberg 17
Toronto 17
Woodbridge 17
Belo Horizonte 16
Jakarta 16
London 16
Zhengzhou 16
Hebei 15
Lawrenceville 15
San Mateo 15
Amsterdam 14
Campinas 14
Lappeenranta 14
Ningbo 14
Palermo 14
Shanghai 14
Guayaquil 13
Lancaster 13
Porto Alegre 13
Shenzhen 13
Baku 12
Columbus 12
Dong Ket 12
Duncan 12
Quito 12
Taizhou 12
Changsha 11
Hangzhou 11
Vienna 11
Baghdad 10
Istanbul 10
Poplar 10
Queens 10
Totale 9.823
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 374
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 352
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 342
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 293
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease 263
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 261
Etanercept for psoriasis and psoriatic arthritis in a patient with Charcot-Marie-Tooth disease 255
Clinical and pathological features of focal myositis 254
A Nouvel serum MicroRNA signature to screen ATTR 237
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 224
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 224
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 208
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 206
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 204
Alexithymia, burden and resilience in ALS’ caregivers 203
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 200
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 191
Comparison Between 99mTc-Diphosphonate Imaging and MRI With Late Gadolinium Enhancement in Evaluating Cardiac Involvement in Patients With Transthyretin Familial Amyloid Polyneuropathy 187
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 187
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 185
Is overwork weakness relevant in Charcot-Marie-Tooth disease? 181
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 180
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 178
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 177
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 177
Bilateral paramedian thalamic infarct after occlusion of the artery of Percheron 176
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 176
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 174
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 174
Autoimmune juvenile limb-girdle myasthenia 173
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 171
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 167
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 166
Are novel outcome measures for Charcot–Marie–Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study 165
Emotional burden and coping strategies in amyotrophic lateral sclerosis caregivers: The role of metacognitions 165
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 164
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 164
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 161
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 161
The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis 161
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 160
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 159
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 158
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 151
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 151
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 151
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 150
Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: data from the national CMT registry 148
La deformazione longitudinale e radiale del ventricolo sinistro è ridotta nell’amiloidosi cardiaca familiare: studio con ecocardiogramma bi-dimensionale e risonanza magnetica cardiaca. 148
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 146
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 140
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS). 140
MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy 139
AUTONOMIC DYSFUNCTION AND HEART INVOLVEMENT IN TRANSTHYRETIN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY 139
Facial onset sensory motor neuronopathy: not always a slowly progressive disorder. 137
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 136
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 135
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 135
Considerable post-partum worsening in a patient with CMT2E 134
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 132
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 132
The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury 130
TRANSTHYRETIN AMYLOIDOSIS IN SOUTHERN ITALY POPULATION: DESCRIPTION OF A COHORT OF PATIENTS WITH PHE64LEU MUTATION AND LATE ONSET 127
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features 126
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone 123
Neurological data collection protocol on tafamidis meglumine treatment for familial amyloid polyneuropathy: preliminary data on patients enrolled by the italian network 122
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 122
Factors predicting survival in ALS: a multicenter Italian study 119
Miopatia prossimale in paziente con sindrome di Williams 117
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 115
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation 114
Repurposing chemotherapy-induced peripheral neuropathy grading 113
Safety and tolerability of orally administered tafamidis meglumine in TTR FAP: preliminary data at 3-month follow-up 113
Very Early Onset of ATTRE89Q Amyloidosis in a Homozygous Patient 113
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 112
Efficacy and quality of life in patients with multifocal motor neuropathy treated by subcutaneous immunoglobulin. 112
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy 109
Corneal Sub-Basal Nerve Plexus in Non-Diabetic Small Fiber Polyneuropathies and the Diagnostic Role of In Vivo Corneal Confocal Microscopy 108
Psychosocial impact of presymptomatic genetic testing for transthyretin amyloidotic polyneuropathy 108
HATTR : Neurotrophic factors expression in schwann cell line after MIR-150 transfection. 107
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 106
L'inibizione dei pathway del fattore nucleare-kappaB, delle MAP chinasi e di COX/5-LOX mediante trattamento con flavocoxid migliora la funzione e la morfologia muscolare nel topo mdx: uno studio comparativo con il metilprednisolone 103
The THAOS: record of patients from our site. 101
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers 101
Phenotypic spectrum of myelin protein zero-related neuropathies: a large cohort study from five mutation clusters across Italy 100
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial 99
From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis 99
Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years 97
Impact of vutrisiran on quality of life and physical function in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy 97
Variable phenotypes are associated with PM22 missense mutations. 96
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy 96
Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry 94
Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. 94
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: Secondary analysis of data from the CI-PeriNomS study 93
Left atrial function in cardiac amyloidosis 93
Molecular profile of transthyretin related familial amyloidotic polyneuropathy: a microarray analysis. 92
Nuclear factor-kappaB, mitogen-activated protein kinases and cyclooxygenase/5-lipoxygenase pathway inhibition by flavocoxid improves muscle function and morphology in mdx mice: a comparison study with methylprednisolone. 91
The role of metacognitive beliefs on anxiety and depression among Amyotrophic Lateral Sclerosis caregivers 91
Prominent distal lower limbs involvement with hyperreflexia in a family with seipin related axonal motorneuropathy. 90
Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy 89
Totale 15.414
Categoria #
all - tutte 61.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.655


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022646 0 0 0 30 49 11 74 41 26 50 59 306
2022/20232.033 165 185 110 149 158 169 20 94 912 7 43 21
2023/2024517 42 77 26 38 53 121 20 32 7 35 15 51
2024/20253.588 46 52 64 177 146 128 186 551 643 170 655 770
2025/20267.907 402 605 585 539 695 1.548 987 954 894 394 150 154
2026/20271.341 244 326 397 374 0 0 0 0 0 0 0 0
Totale 18.180